FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998891566> ?p ?o ?g. }

• W1998891566 endingPage "12" @default.
• W1998891566 startingPage "3" @default.
• W1998891566 abstract "ObjectivesTo compare the effect of optimal medical treatment only (OMT) with OMT combined with percutaneous transluminal angioplasty (OMT+PTA) in patients with intermittent claudication (IC).DesignA single centre prospective, randomised study. Quality of life (QoL) was the primary outcome measure. Secondary measures were ankle-brachial-index (ABI), treadmill walking distances and mortality.MethodsFrom a total of 434 patients considered for inclusion into the trial, only 56 patients with disabling IC fulfilled the inclusion criteria. The patients were randomised into treatment groups consisting of 28 patients each and followed for 2 years. ABI and treadmill walking distances were measured in addition to the visual analogue scale (VAS) for pain evaluation, and QoL assessment using the Short Form (SF-36 and Claudication Scale (CLAU-S).ResultsThe demographic data in the 2 groups were almost identical. After 2 years of follow-up the ABI, the treadmill walking distances and the VAS were significant improved in the group treated with OMT+PTA, compared to the group treated with OMT only (p<0.01 for all). Furthermore, some variables from the QoL assessment also showed a significant improvement in favour of the OMT+PTA group (p<0.05 for all).ConclusionThe advantage of conducting a single centre study and adhering to very strict inclusion criteria was illustrated by the homogenous demographic data of the two groups. This partly outweighed the disadvantage of having included a relatively small number of patients. Early intervention with PTA in addition to OMT seems to have a generally more positive effect compared to OMT only, on haemodynamic, functional as well as QoL aspects during the first 2 years in patients with IC. To compare the effect of optimal medical treatment only (OMT) with OMT combined with percutaneous transluminal angioplasty (OMT+PTA) in patients with intermittent claudication (IC). A single centre prospective, randomised study. Quality of life (QoL) was the primary outcome measure. Secondary measures were ankle-brachial-index (ABI), treadmill walking distances and mortality. From a total of 434 patients considered for inclusion into the trial, only 56 patients with disabling IC fulfilled the inclusion criteria. The patients were randomised into treatment groups consisting of 28 patients each and followed for 2 years. ABI and treadmill walking distances were measured in addition to the visual analogue scale (VAS) for pain evaluation, and QoL assessment using the Short Form (SF-36 and Claudication Scale (CLAU-S). The demographic data in the 2 groups were almost identical. After 2 years of follow-up the ABI, the treadmill walking distances and the VAS were significant improved in the group treated with OMT+PTA, compared to the group treated with OMT only (p<0.01 for all). Furthermore, some variables from the QoL assessment also showed a significant improvement in favour of the OMT+PTA group (p<0.05 for all). The advantage of conducting a single centre study and adhering to very strict inclusion criteria was illustrated by the homogenous demographic data of the two groups. This partly outweighed the disadvantage of having included a relatively small number of patients. Early intervention with PTA in addition to OMT seems to have a generally more positive effect compared to OMT only, on haemodynamic, functional as well as QoL aspects during the first 2 years in patients with IC." @default.
• W1998891566 created "2016-06-24" @default.
• W1998891566 creator A5020199745 @default.
• W1998891566 creator A5022412145 @default.
• W1998891566 creator A5023041920 @default.
• W1998891566 creator A5033597776 @default.
• W1998891566 creator A5050830997 @default.
• W1998891566 creator A5058339792 @default.
• W1998891566 creator A5071453220 @default.
• W1998891566 creator A5072411437 @default.
• W1998891566 creator A5072637485 @default.
• W1998891566 creator A5075116484 @default.
• W1998891566 creator A5084461040 @default.
• W1998891566 date "2007-01-01" @default.
• W1998891566 modified "2023-10-15" @default.
• W1998891566 title "The Oslo Balloon Angioplasty versus Conservative Treatment Study (OBACT)—The 2-years Results of a Single Centre, Prospective, Randomised Study in Patients with Intermittent Claudication" @default.
• W1998891566 cites W136657926 @default.
• W1998891566 cites W1502524639 @default.
• W1998891566 cites W1545889596 @default.
• W1998891566 cites W180946569 @default.
• W1998891566 cites W1968045384 @default.
• W1998891566 cites W1974487821 @default.
• W1998891566 cites W1987954250 @default.
• W1998891566 cites W1998545414 @default.
• W1998891566 cites W1999927910 @default.
• W1998891566 cites W2003849704 @default.
• W1998891566 cites W2005251975 @default.
• W1998891566 cites W2022536824 @default.
• W1998891566 cites W2022554332 @default.
• W1998891566 cites W2032402683 @default.
• W1998891566 cites W2032703165 @default.
• W1998891566 cites W2040719821 @default.
• W1998891566 cites W2043398549 @default.
• W1998891566 cites W2046921873 @default.
• W1998891566 cites W2048381379 @default.
• W1998891566 cites W2051337042 @default.
• W1998891566 cites W2051867540 @default.
• W1998891566 cites W2069657510 @default.
• W1998891566 cites W2070708034 @default.
• W1998891566 cites W2073412482 @default.
• W1998891566 cites W2074641075 @default.
• W1998891566 cites W2084667881 @default.
• W1998891566 cites W2091813490 @default.
• W1998891566 cites W2093397264 @default.
• W1998891566 cites W2093983853 @default.
• W1998891566 cites W2102505453 @default.
• W1998891566 cites W2105029005 @default.
• W1998891566 cites W2112145767 @default.
• W1998891566 cites W2115456218 @default.
• W1998891566 cites W2127950476 @default.
• W1998891566 cites W2141051547 @default.
• W1998891566 cites W2155942116 @default.
• W1998891566 cites W4251364778 @default.
• W1998891566 doi "https://doi.org/10.1016/j.ejvs.2006.08.007" @default.
• W1998891566 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17055756" @default.
• W1998891566 hasPublicationYear "2007" @default.
• W1998891566 type Work @default.
• W1998891566 sameAs 1998891566 @default.
• W1998891566 citedByCount "69" @default.
• W1998891566 countsByYear W19988915662012 @default.
• W1998891566 countsByYear W19988915662013 @default.
• W1998891566 countsByYear W19988915662014 @default.
• W1998891566 countsByYear W19988915662015 @default.
• W1998891566 countsByYear W19988915662016 @default.
• W1998891566 countsByYear W19988915662017 @default.
• W1998891566 countsByYear W19988915662018 @default.
• W1998891566 countsByYear W19988915662019 @default.
• W1998891566 countsByYear W19988915662020 @default.
• W1998891566 countsByYear W19988915662021 @default.
• W1998891566 countsByYear W19988915662022 @default.
• W1998891566 countsByYear W19988915662023 @default.
• W1998891566 crossrefType "journal-article" @default.
• W1998891566 hasAuthorship W1998891566A5020199745 @default.
• W1998891566 hasAuthorship W1998891566A5022412145 @default.
• W1998891566 hasAuthorship W1998891566A5023041920 @default.
• W1998891566 hasAuthorship W1998891566A5033597776 @default.
• W1998891566 hasAuthorship W1998891566A5050830997 @default.
• W1998891566 hasAuthorship W1998891566A5058339792 @default.
• W1998891566 hasAuthorship W1998891566A5071453220 @default.
• W1998891566 hasAuthorship W1998891566A5072411437 @default.
• W1998891566 hasAuthorship W1998891566A5072637485 @default.
• W1998891566 hasAuthorship W1998891566A5075116484 @default.
• W1998891566 hasAuthorship W1998891566A5084461040 @default.
• W1998891566 hasBestOaLocation W19988915661 @default.
• W1998891566 hasConcept C126322002 @default.
• W1998891566 hasConcept C141071460 @default.
• W1998891566 hasConcept C14184104 @default.
• W1998891566 hasConcept C159110408 @default.
• W1998891566 hasConcept C168563851 @default.
• W1998891566 hasConcept C1862650 @default.
• W1998891566 hasConcept C188816634 @default.
• W1998891566 hasConcept C2777466421 @default.
• W1998891566 hasConcept C2778640784 @default.
• W1998891566 hasConcept C2778963770 @default.
• W1998891566 hasConcept C2779881954 @default.
• W1998891566 hasConcept C2779951463 @default.
• W1998891566 hasConcept C2780326628 @default.
• W1998891566 hasConcept C2780813298 @default.

• next